Commercial Due Diligence for Private Equity: The Definitive Guide for 2026

Commercial due diligence (CDD) is the systematic, forward-looking assessment of a target company's market position, competitive landscape, customer dynamics, and growth potential — conducted as part of the investment evaluation process.

If financial due diligence tells you where a company has been, commercial due diligence tells you where it's going — and whether the investment thesis behind a deal actually holds up against market reality.

CDD sits within a broader PE due diligence framework that typically encompasses five key areas:

• Commercial — market position, competitive dynamics, and growth potential
• Financial — historical performance verification, quality of earnings, and valuation
• Legal — compliance, liabilities, and contractual risks
• Management & Operations — leadership quality, operational efficiency, and improvement opportunities
• Technology / IT — infrastructure, cybersecurity, and (increasingly) AI readiness

CDD is the connective tissue between all of these. It's the workstream that validates whether the market opportunity is real, whether customers actually value what the target sells, and whether the growth plan in the CIM is grounded in reality — or wishful thinking.

Types of CDD

Not all CDD engagements are created equal. The scope and depth vary depending on deal context:

• Buy-side CDD — The most common form. Commissioned by the prospective buyer to provide an all-encompassing overview of the target company's commercial viability, market position, and growth potential before committing capital.
• Vendor (sell-side) CDD — Initiated by the seller before going to market. Smart sellers conduct due diligence on their own business to anticipate buyer questions, address red flags proactively, and build a stronger narrative that supports valuation expectations.
• Red flag CDD — An expedited, high-level assessment designed to identify deal-breakers early, before committing significant time and resources to a full-scope review. Common in competitive auction processes where speed matters.
• Top-up CDD — Supplementary diligence in specific areas where the existing analysis needs to be deepened. Often used when new information surfaces mid-process or when a deal team needs to pressure-test a specific assumption.

Why CDD Matters More Than Ever in 2026

We've always believed CDD is the most important diligence workstream. But in 2026, the market dynamics make it non-negotiable.

Record capital is chasing a finite pool of quality assets

Global PE dry powder has surged to $2.59 trillion, with the U.S. market alone accounting for a record $1.1 trillion of unallocated capital. A surplus of capital doesn't equate to a surplus of quality. It's created a liquidity logjam where record competition for A-tier assets forces deal teams to work significantly harder — and smarter — to win deals and generate returns.

Deal activity has rebounded, but scrutiny must match pace

PE deal value hit $1.2 trillion in 2025 — only the second time annual deal value has crossed the trillion-dollar threshold, after 2021. Both deal value and deal volumes are expected to exceed 2025 levels this year, with volumes returning toward historical norms. More deals means more diligence. And more competition means less room for error.

Elevated valuations demand justification

When you're paying 12–15x EBITDA for a mid-market platform, you need more than a banker's hockey stick to justify the price. Buyers are increasingly emphasising comprehensive due diligence to demonstrate that projected cash flows, growth potential, and strategic advantages truly support the elevated multiples. CDD is where that justification lives — or dies.

The shift from financial engineering to value creation

Private equity firms are moving away from growth-at-any-cost strategies toward operational value creation, deeper diligence, and more disciplined risk underwriting. In 2026, outperformance will increasingly be driven by operational improvement, sector specialisation, and data-enabled transformation — not leverage and multiple expansion. CDD provides the commercial foundation for that value creation roadmap.

The cost of getting it wrong

Inadequate due diligence can destroy value significantly and irreversibly. One poor investment can drag down the performance of an entire fund for years. Meanwhile, the backlog of PE portfolio companies — more than 4,000 in the U.S. aged over five years — waiting to exit continues to grow. The median holding period for a U.S. PE-backed company hit 3.4 years in 2024, the longest in nearly a decade. When exits take longer and returns are harder to generate, getting the entry right matters more than ever.

The CDD Process: Step by Step

PE due diligence happens in two phases: exploratory and confirmatory. Understanding this framework is essential for scoping CDD work effectively.

Phase 1: Exploratory Due Diligence

In the exploratory phase, the deal team assesses immediate fit against the fund's investment thesis. This is where you're answering the fundamental question: Should we spend more time on this?

Typical CDD activities at this stage include:

• Reviewing the CIM and management presentation with a critical eye
• Conducting rapid market sizing and landscape analysis
• Identifying the key commercial questions the deal hinges on
• Running initial expert calls or red-flag assessments to surface obvious risks
• Benchmarking the target's positioning against known competitors

This phase is about speed and signal — not exhaustive analysis. The output is typically an internal investment memo or preliminary assessment that supports (or rejects) moving forward to confirmatory diligence.

Phase 2: Confirmatory Due Diligence

If the target passes initial screening, the deal team moves to confirmatory due diligence. Here, the team spends significantly more time and resources to validate the information the target company has provided. Assumptions are tested. Third parties — consultants, lawyers, primary research providers — are typically engaged.

Core CDD workstreams in this phase include:

• Market analysis — Deep dive into market size, growth drivers, segmentation, and structural trends. Is the market growing? Is growth cyclical or structural? What are the headwinds?
• Competitive landscape — Who are the real competitors? How defensible is the target's position? What are the switching costs? Where is competitive intensity increasing?
• Customer validation — What do customers actually think? Is there concentration risk? How sticky is the revenue? Are Net Promoter Scores and renewal rates what management claims?
• Management plan assessment — Are the revenue projections realistic? What assumptions underpin the growth plan? Where has management been optimistic (or deliberately vague)?
• Pricing and revenue model analysis — How sustainable is the pricing structure? Is there pricing power? Are there risks from commoditisation or competitive pressure?
• Growth levers and value creation opportunities — What are the realistic pathways for post-acquisition growth? Are there expansion opportunities in adjacent markets, new customer segments, or product extensions?

The output of confirmatory CDD is typically a comprehensive report that feeds directly into the investment committee memo, the equity case, and the banking case used to support acquisition financing. The findings play a crucial role in the go/no-go decision, helping define valuation, deal structure, and negotiation terms.

Typical Timeline

The timeline for CDD varies depending on deal complexity. An initial red-flag review might take one to two weeks. A full confirmatory CDD engagement typically runs three to six weeks, though competitive auction processes frequently compress this further. This time pressure is one of the reasons choosing the right research approach — and the right research partners — matters so much.

The Role of Primary Research in CDD

This is where we have a strong point of view: primary research is the single most important differentiator in commercial due diligence.

Desktop research — industry reports, public filings, analyst notes, news articles — gives you the baseline. Every deal team has access to it. It's table stakes. What separates rigorous CDD from box-ticking is proprietary primary research: direct conversations with customers, competitors, suppliers, former employees, and industry experts who can tell you what's actually happening on the ground.

Why desktop research alone is insufficient

Target companies in PE transactions are usually not publicly listed, making information gathering inherently more difficult. The CIM is a sales document — it's designed to present the business in its best light. Management presentations are, by definition, biased. Without independent validation from the people who buy from, compete with, and operate alongside the target, you're making a multi-million-dollar decision based on one side of the story.

Key primary research methodologies for CDD

• Expert interviews — Conversations with industry operators, former executives, and sector specialists who can provide context, validate assumptions, and surface risks that don't appear in any document.
• Customer interviews and surveys — Direct feedback from the target's customer base on satisfaction, switching intent, competitive alternatives, and willingness to pay. This is where you find out if the revenue is truly sticky.
• Channel checks — Conversations with distributors, partners, and channel participants that reveal how the target is perceived in the market and how its products or services compare to alternatives.
• Competitor analysis — Primary-sourced intelligence on competitive positioning, market share dynamics, and strategic direction from people who operate in the same space.
• B2B surveys — Structured quantitative research with market participants to size opportunities, validate trends, and benchmark performance.

Expert networks vs. done-for-you research

There are broadly two models for sourcing primary research in a deal context:

Traditional expert networks (GLG, AlphaSights, Third Bridge, Guidepoint) provide access to experts. They match you with relevant people and facilitate calls. But the deal team does the work — writing discussion guides, conducting interviews, scheduling calls, and synthesising findings across multiple conversations.

Done-for-you research providers handle the entire process end-to-end. You brief the team on what you need to know, and they design the methodology, conduct the interviews or surveys, analyse the data, and deliver finished research outputs. No scheduling. No synthesis. No managing 15 separate expert transcripts.

The right choice depends on your team's capacity, timeline, and how much bandwidth you can dedicate to running research yourself. For lean deal teams running competitive auction processes — which describes most mid-market PE — the done-for-you model increasingly makes sense. It's not about capability; it's about opportunity cost.

How to structure research around deal questions

The most effective CDD primary research starts with a clear, testable deal thesis. Rather than conducting broad, exploratory research, the best approach is to define the specific investment questions the deal hinges on and design research to answer them directly.

For example:

• "Management claims 90% gross retention. Do customers corroborate that? What are the real switching costs?"
• "The thesis depends on 15% annual market growth. Do industry participants see that trajectory, or is it decelerating?"
• "The target says it's the market leader. How do competitors and channel partners perceive its position?"

Defining the research objective clearly ensures the study focuses on key investment questions rather than gathering extraneous information. Every expert call, every survey question, every channel check should ladder up to a specific element of the deal thesis.

Who Does CDD: The Landscape

Understanding who provides CDD — and what each type of provider is best suited for — helps deal teams allocate resources effectively.

Management consulting firms

Tier 1 (MBB): Firms like Bain, BCG, and McKinsey occasionally take on CDD work, especially for long-standing clients or high-profile, large-cap deals. Bain has worked on more than 18,000 due diligence projects. BCG's research shows that BCG-assisted mergers create 9% more shareholder value than average in the first 24 months. However, these firms are selective, expensive, and typically focused on broader strategy engagements.

Tier 2 (Dedicated CDD firms): Firms like EY-Parthenon, L.E.K. Consulting, OC&C, Strategy&, Kearney, Alvarez & Marsal, and CIL Management Consultants are much more active in the CDD space. Many have dedicated transaction advisory teams that handle dozens or hundreds of CDD projects annually. They bring sector expertise and structured frameworks, and their reports carry weight with investment committees and lenders.

Expert networks

Traditional expert networks have become critical to modern private equity, helping deal teams move faster, validate assumptions, and make sharper investment decisions. The best networks match deal teams with operators who have direct, recent experience in the exact market or customer set being evaluated. Relevancy matters more than panel size.

Done-for-you primary research providers

A growing category that sits between expert networks and consulting firms. These providers handle the full research process — from methodology design through expert sourcing, fieldwork, analysis, and deliverable production. They offer investment-grade primary research without the overhead of a full consulting engagement or the DIY burden of expert networks.

When to use which

There's no single right answer. Many sophisticated deal teams use a combination:

• Consulting firms for comprehensive CDD reports that carry weight with investment committees and lenders, particularly on large or complex deals
• Expert networks for rapid, ad hoc expert access when the deal team has capacity to run the calls themselves
• Done-for-you research providers for structured primary research programs — customer surveys, competitive studies, market validation — especially when the deal team is bandwidth-constrained or needs finished research outputs rather than raw transcripts

PE firms are increasingly unbundling the primary research component of CDD from expensive strategy consulting engagements. If you're paying a consulting firm $500K for a CDD report, a meaningful portion of the value comes from the primary research underlying it. Sourcing that research directly — and more efficiently — is a trend that's accelerating.

Common CDD Pitfalls and How to Avoid Them

Too many deal teams treat due diligence as a box-ticking exercise. They focus on the numbers but miss the narrative. They analyse the past but fail to anticipate the future. Here are the most common mistakes we see — and how to avoid them.

1. Over-reliance on management narratives

The CIM is a marketing document. Management presentations are inherently optimistic. CDD that fails to independently validate management claims via primary research is fundamentally flawed. One illustrative example: L.E.K.'s independent assessment of a target company's management revenue projections led to the PE client placing a lower bid than originally expected — saving them from overpaying based on the seller's narrative.

The fix: Every material management claim should be independently verified through primary research. If management says customers love the product, talk to customers. If they say the market is growing at 20%, ask industry participants. If they say competition is limited, run competitive channel checks.

2. Box-ticking CDD vs. thesis-driven CDD

Generic CDD that covers every possible angle at a surface level is less valuable than focused CDD that ruthlessly tests the specific assumptions the deal depends on. If your CDD report reads like a market overview, it's not doing its job.

The fix: Start with a clear, testable deal thesis. Identify the three to five assumptions that, if wrong, would change the investment decision. Structure every workstream around validating or challenging those assumptions.

3. Ignoring customer concentration risk

If commercial diligence reveals that a large portion of the target's revenue comes from a single customer or a small group of customers, this represents a significant financial risk. This concentration must be factored into valuation and the post-acquisition strategy. Too many deal teams note concentration as a finding without quantifying the impact or developing a mitigation plan.

The fix: Go beyond identifying concentration — talk to the key accounts. Understand contract terms, switching likelihood, competitive alternatives, and the relationship's true strength. Model downside scenarios.

4. Not linking CDD to value creation

CDD shouldn't end with a go/no-go recommendation. The best CDD produces a clear roadmap for creating value post-close — identifying the specific commercial levers (pricing optimisation, market expansion, cross-sell opportunities, competitive positioning improvements) that will drive returns.

The fix: Frame CDD findings in terms of actionable value creation initiatives. Conducted early, CDD ensures go-to-market strategies are market-aligned and ready to be executed from Day 1.

5. Coordination bottlenecks across workstreams

Due diligence can be time- and labour-intensive, requiring PE firms to review hundreds of pages of documents across multiple workstreams. Because many different teams are involved, the process often creates bottlenecks that slow down the deal. Given the density and volume of materials under review, critical risks can be overlooked or analysed inconsistently.

The fix: Due diligence is most effective when it's cross-functional. Bringing in specialists from finance, legal, operations, technology, and commercial research ensures a deeper, more well-rounded assessment and surfaces issues that generalists alone would miss.

6. Conducting CDD too late

Waiting until confirmatory diligence to start commercial research means you've already invested significant time and resources before discovering potential deal-breakers.

The fix: Initiate at least a red-flag CDD assessment during the exploratory phase. Early primary research — even a handful of well-targeted expert calls — can surface issues that save weeks of wasted effort.

AI and the Future of CDD

AI is changing CDD workflows. But the conversation around AI in due diligence is often more hype than substance. Here's what's actually happening.

What AI is changing

AI is restructuring how information is processed inside the diligence workflow. The real shift is from manual review to structured signal extraction. Instead of reading transcripts sequentially, teams can synthesise hundreds of expert conversations in minutes. EY's benchmark testing shows productivity gains of 35–85%, with some diligence tasks compressing from weeks to days.

Nearly half of dealmakers (49%) now use AI tools nearly every day. Firms are embracing AI applications across the investment lifecycle — from deal sourcing to due diligence, fraud detection, portfolio monitoring, and standardised reporting.

What AI is not changing

AI does not replace analysts, make investment decisions, or remove the need for expert calls. The human judgment layer — talking to customers, reading between the lines in expert conversations, interpreting competitive dynamics that don't fit neatly into a dataset — remains irreplaceable.

The most important CDD insights come from asking the right questions to the right people. No AI model can replicate the insight you get from a 45-minute conversation with a former VP of Sales at the target's largest competitor, or a candid discussion with a long-tenured customer about why they're considering switching vendors.

AI as a new diligence dimension

Beyond using AI in diligence, AI readiness is becoming a diligence dimension in its own right. Deal teams are now assessing where AI can drive cost efficiency, improve throughput, and enhance decision-making across the target's operations — evaluating AI readiness, execution risk, and value creation potential. Half of PE respondents believe generative AI and agentic AI will have the most transformative impact on their industry over the next three years.

The bottom line on AI and CDD

Use AI to accelerate the mechanical parts of diligence — document review, transcript synthesis, pattern detection, data aggregation. But don't confuse faster processing with better judgment. The differentiated insights that drive deal conviction still come from human-led primary research.

CDD Across Deal Types and Sectors

Platform acquisitions vs. add-ons

Platform acquisitions demand full-scope CDD — you're underwriting the entire market thesis, competitive position, and management team. Add-on acquisitions require more targeted CDD focused on integration fit, customer overlap, and whether the combined entity is stronger than the sum of its parts.

Sector-specific considerations

CDD priorities shift by sector. In software, customer retention metrics, net revenue retention, and competitive feature comparison dominate. In healthcare, regulatory dynamics and reimbursement trends are critical. In industrials, channel relationships and pricing power matter more. In consumer businesses, brand perception and channel checks become central. The methodology must adapt — a B2B survey of hospital administrators looks very different from a channel check with industrial distributors.

Cross-border nuances

Cross-border deals add layers of complexity: different competitive dynamics by geography, regulatory environments, customer behaviour patterns, and channel structures. Primary research across multiple markets requires providers with genuine international reach and local-language capabilities.

Putting It All Together: A CDD Framework That Works

Based on everything above, here's what separates excellent CDD from the generic variety:

1. Start with a testable thesis. Define the three to five assumptions the deal depends on. Structure all diligence around validating or challenging those assumptions.
2. Invest in primary research early. Don't wait for confirmatory diligence to start talking to customers, experts, and competitors. Even exploratory-phase expert calls can surface deal-breakers.
3. Combine internal and external perspectives. Integrate management's view with independent market feedback. Without this dual lens, you risk underestimating capability constraints or overestimating market tailwinds.
4. Be willing to kill the deal. The most valuable CDD isn't the report that confirms what you already believed. It's the research that gives you genuine conviction — or the courage to walk away before you overpay.
5. Link findings to value creation. CDD should produce a clear roadmap for post-close commercial initiatives, not just a market overview. The best CDD reports shape the first 100 days strategy.
6. Choose the right research partners. Match the provider to the need. Use consulting firms for comprehensive CDD reports, expert networks for ad hoc access, and done-for-you research providers for structured primary research programs that deliver finished, actionable outputs on deal timelines.

How Woozle Research Supports CDD

We built Woozle Research specifically for this use case. Investment teams brief us on what they need to know — the deal thesis, the key commercial questions, the specific assumptions they need to validate — and we handle the rest.

We design the methodology, source and vet the right experts, conduct the interviews and surveys, analyse the data, and deliver finished research outputs that plug directly into the diligence process. No scheduling calls. No writing discussion guides. No synthesising 15 separate transcripts.

Our clients — PE deal teams, consulting firms running CDD engagements, hedge fund analysts, and corporate M&A teams — use us because they need investment-grade primary research on deal timelines, without the operational burden of doing it themselves.

If you're running a deal and need primary research to support your commercial diligence, get in touch with our team. We'll scope the work and move fast.